ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

CLDX Celldex Therapeutics Inc

38.21
-1.73 (-4.33%)
May 18 2024 - Closed
Delayed by 15 minutes

Celldex Therapeutics Financial Summary

The current CLDX market cap is 2.14B. The company's latest EPS is USD -2.5300 and P/E is -15.10.

Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 967k267k1.52M4.13M156k
Operating Income -32.47M-33.21M-41.24M-47.63M-40.61M
Net Income -29.36M-30.5M-38.26M-43.31M-32.81M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 4.87M11.64M6.06M9.22M6.88M
Operating Income -53.23M-63.35M-71.24M-115.23M-154.54M
Net Income -50.88M-59.78M-70.51M-112.33M-141.43M
Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 324.52M299.31M280.26M465.63M868.85M
Total Liabilities 21.78M21.77M33.54M36.46M30.23M
Total Equity 302.74M277.54M246.72M429.17M838.61M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 122.93M235.84M444.65M352.74M465.63M
Total Liabilities 28.91M26.48M25.18M26.53M36.46M
Total Equity 94.03M209.36M419.48M326.2M429.17M
Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating -28.57M-55.77M-74.76M-107.29M-40.64M
Investing 52.57M53.73M65.38M-105.78M-315.21M
Financing 694k827k1.08M218.46M436.11M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating -46.42M-40.4M-60.91M-103.73M-107.29M
Investing 17.08M-98.22M-216.16M89.94M-105.78M
Financing 16.26M171.23M272.37M4.08M218.46M
Market Cap 2.14B
Price to Earnings Ratio -15.10
Price to Sales Ratio 310.4
Price to Cash Ratio 61.35
Price to Book Ratio 4.98
Dividend Yield -

Share Statistics

Shares Outstanding 55.9M
Average Volume (1 week) 587.38k
Average Volume (1 Month) 582.52k
52 Week Change 14.92%
52 Week High 53.18
52 Week Low 22.11
Spread (Intraday) 5.9 (14.54%)

Company Info

Company Name Celldex Therapeutics Inc
Address 1209 orange street
wilmington, delaware 19801
Website https://www.celldex.com
Industry in vitro,in vivo diagnostics (2835)

Your Recent History

Delayed Upgrade Clock